TNF inhibitors and risk of malignancy in patients with inflammatory bowel diseases: a systematic review

Inflammatory Bowel Disease

Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases

Inflamm Bowel Dis.

Attauabi M, Zhao M, Bendtsen F, Burisch J

doi: 10.1093/ibd/izaa167.

Inflammatory Bowel Disease

Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients with Inflammatory Bowel Diseases: a Systematic Review and Meta-analysis

Clin Gastroenterol Hepatol.

Singh S, Facciorusso A, Dulai PS, Jairath V, Sandborn WJ

doi: 10.1016/j.cgh.2019.02.044.

Inflammatory Bowel Disease

The risk of rheumatoid arthritis among patients with inflammatory bowel disease: a systematic review and meta-analysis

BMC Gastroenterol.

Chen Y, Chen L, Xing C, Deng G, Zeng F, Xie T, Gu L, Yang H

doi: 10.1186/s12876-020-01339-3.

Inflammatory Bowel Disease

A Systematic Review on Cost-effectiveness Analyses of Therapeutic Drug Monitoring for Patients with Inflammatory Bowel Disease: From Immunosuppressive to Anti-TNF Therapy

Inflamm Bowel Dis.

Yao J, Jiang X, You JHS

doi: 10.1093/ibd/izaa073.

Inflammatory Bowel Disease

The Treatment of Inflammatory Bowel Disease in Patients With a History of Malignancy

Inflamm Bowel Dis.

Lin SC, Goldowsky A, Papamichael K, Cheifetz AS

doi: 10.1093/ibd/izy376.

Inflammatory Bowel Disease

Risk and outcomes of coronavirus disease (COVID-19) in patients with inflammatory bowel disease: a systematic review and meta-analysis

United European Gastroenterol J

Singh AK, Jena A, Kumar-M P, Sharma V, Sebastian S

doi: 10.1177/2050640620972602

Inflammatory Bowel Disease

The Risk of Adverse Neonatal Outcomes With Maternal Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

Inflamm Bowel Dis.

Leung KK, Tandon P, Govardhanam V, Maxwell C, Huang V

doi: 10.1093/ibd/izaa122.

Inflammatory Bowel Disease

Risk of Postoperative Infectious Complications From Medical Therapies in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Inflamm Bowel Dis.

Law CCY, Koh D, Bao Y, Jairath V, Narula N

doi: 10.1093/ibd/izaa020.

Inflammatory Bowel Disease

Risk of bacteremia in hospitalised patients with inflammatory bowel disease: a 9-year cohort study

United European Gastroenterol J.

Goren I, Brom A, Yanai H, Dagan A, Segal G, Israel A

doi: 10.1177/2050640619874524.

Related content

Systematic Review with Meta-analysis: The Impact of Co-occurring Immune-mediated Inflammatory Diseases on the Disease Course of Inflammatory Bowel Diseases

Comparative Risk of Serious Infections With Biologic and/or Immunosuppressive Therapy in Patients with Inflammatory Bowel Diseases: a Systematic Review and Meta-analysis

The risk of rheumatoid arthritis among patients with inflammatory bowel disease: a systematic review and meta-analysis

A Systematic Review on Cost-effectiveness Analyses of Therapeutic Drug Monitoring for Patients with Inflammatory Bowel Disease: From Immunosuppressive to Anti-TNF Therapy

The Treatment of Inflammatory Bowel Disease in Patients With a History of Malignancy

Risk and outcomes of coronavirus disease (COVID-19) in patients with inflammatory bowel disease: a systematic review and meta-analysis

The Risk of Adverse Neonatal Outcomes With Maternal Inflammatory Bowel Disease: A Systematic Review and Meta-analysis

Risk of Postoperative Infectious Complications From Medical Therapies in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

Risk of bacteremia in hospitalised patients with inflammatory bowel disease: a 9-year cohort study